In a filing, Resmed Inc. revealed its Director FARRELL PETER C unloaded Company’s shares for reported $0.47 million on Oct 02 ’24. In the deal valued at $237.20 per share,2,000 shares were sold. As a result of this transaction, FARRELL PETER C now holds 85,204 shares worth roughly $19.94 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, FARRELL PETER C bought 2,000 shares, generating $477,500 in total proceeds.
Before that, Ghoshal Kaushik sold 5,000 shares. Resmed Inc. shares valued at $1,262,800 were divested by the Chief Commercial Officer, SaaS at a price of $252.56 per share. As a result of the transaction, Ghoshal Kaushik now holds 21,788 shares, worth roughly $5.1 million.
Robert W. Baird initiated its Resmed Inc. [RMD] rating to an Outperform in a research note published on September 24, 2024; the price target was $280. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who decreased its forecast for the stock in mid September from “a Peer perform” to “an Underperform”. Needham also remained covering RMD and has decreased its forecast on September 04, 2024 with a “Hold” recommendation from previously “Buy” rating. Oppenheimer revised its rating on June 25, 2024. It rated RMD as “a Perform” which previously was an “an Outperform”.
Price Performance Review of RMD
On Friday, Resmed Inc. [NYSE:RMD] saw its stock fall -1.87% to $233.98. Over the last five days, the stock has lost -2.10%. Resmed Inc. shares have risen nearly 36.02% since the year began. Nevertheless, the stocks have risen 58.08% over the past one year. While a 52-week high of $255.18 was reached on 09/09/24, a 52-week low of $132.24 was recorded on 01/04/24. SMA at 50 days reached $233.08, while 200 days put it at $202.98.
Levels Of Support And Resistance For RMD Stock
The 24-hour chart illustrates a support level at 231.79, which if violated will result in even more drops to 229.60. On the upside, there is a resistance level at 237.82. A further resistance level may holdings at 241.66. The Relative Strength Index (RSI) on the 14-day chart is 42.95, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -4.81, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 89.03%. Stochastics %K at 24.63% indicates the stock is a holding.
How much short interest is there in Resmed Inc.?
A steep rise in short interest was recorded in Resmed Inc. stocks on 2024-09-13, dropping by -1.2 million shares to a total of 8.58 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-15 was 9.78 million shares. There was a decline of -13.93%, which implies that there is a negative sentiment for the stock.
